Canadian Rheumatology Association Meeting Quebec City Convention Centre Quebec City, Quebec, Canada February 8–11, 2023

The 77th Annual Meeting of the Canadian Rheumatology Association was held both in person at the Quebec City Convention Centre in Quebec City, Quebec, Canada, and virtually on February 8-11, 2023. The program consisted of presentations covering original research, symposia, awards, and lectures. Highlights of the meeting include the following 2023 Award Winners: Distinguished Rheumatologist, Gilles Boire; Distinguished Investigator, Murray Baron; Distinguished Teacher-Educator, Janet Pope; Emerging Investigator, Lihi Eder; Emerging Teacher-Educator, Steven Thomson; Ian Watson Award for the Best Abstract on SLE Research by a Trainee, Laura Whittall-Garcia; Phil Rosen Award for the Best Abstract on Clinical or Epidemiology Research by a Trainee, Timothy Kwok; Best Abstract on Research by a Rheumatology Resident, Mats Junek; Best Abstract on Basic Science Research by a Trainee, Marie-Hélène Normand; Best Abstract by a Post-Graduate Research Trainee, Leah Flatman; Best Abstract on Quality Care Initiatives in Rheumatology, Amanda Steiman; Best Abstract by a Medical Student, Shakeel Subdar; Best Abstract by an Undergraduate Student, Jeremiah Tan; Best Abstract by a Rheumatology Post-Graduate Research Trainee, Nicole Andersen; Best Abstract on Research by Young Faculty, Alexandra Legge; Best Abstract on Spondyloarthritis Research, Patricia Remalante-Rayco; Practice Reflection Award, Gold, Carrie Ye and Janet Roberts; Practice Reflection Award, Silver, Lillian Lim. Lectures and other events included: Keynote Lecture by Fiona Rawle: Communicating Science to Patients: Complexities & Caveats; Keynote Address by Murray Baron, Distinguished Investigator Awardee: New Outcome Measures for Systemic Sclerosis; State of the Art Lecture by John Isaacs: Precision Medicine in RA - The Precision Gap; Dunlop-Dottridge Lecture by Rae Yeung: What's in a Name? That Which We Call JIA, By Any Other Name, Would It Still Be the Same Childhood Arthritis?; and the Great Debate: Be it Resolved that Canadians With New Inflammatory Arthritis Should Have Access to All Therapeutic Options at Disease Onset to Induce Remission. Arguing for: Cory Baillie and Anne MacLeod, and against: Michelle Batthish and Louis Bessette. Topics including rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, Sjögren syndrome, psoriatic arthritis, spondyloarthritis, vasculitis, osteoarthritis, fibromyalgia, and their respective diagnoses, treatments, and outcomes are reflected in the abstracts, which we are pleased to publish in this issue of The Journal of Rheumatology.